CASµÇ¼ºÅ | ÖÐÎÄÃû | Ó¢ÎÄÃû | ·Ö×ӽṹʽ | ·Ö×Óʽ | ÏêÇé | ¹©Ó¦ÉÌ |
177-11-7 | 4-ßßà¤ÍªËõÒÒ¶þ´¼ | 1,4-Dioxa-8-Azaspiro[4.5]decane; 4-Piperidone ethylene ketal | C7H13NO2 | ÏêÇé | ¹©Ó¦ÉÌ | |
1075-89-4 | 3,3-ËÄÑǼ׻ùÎì¶þõ£ÑÇ°·; 8-µªÔÓÂÝ[4,5]¹ïÍé-7,9-¶þͪ | 3,3-Tetramethyleneglutarimide; 8-Azaspiro[4,5]decane-7,9-dione | C9H13NO2 | ÏêÇé | ¹©Ó¦ÉÌ | |
33386-08-2 | ÑÎËᶡÂÝ»·Íª; ¶¡ÂÝ»·ÍªÑÎËáÑÎ; N-[4-[4-(2-à×ऻù)-1-ßßົù]¶¡»ù]-8-µªÔÓÂÝ[4,5]¹ïÍé-7,9-¶þͪÑÎËáÑÎ | Buspirone hydrochloride; N-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-Azaspiro[4.5]decane-7,9-dione hydrochloride | C21H32ClN5O2 | ÏêÇé | ¹©Ó¦ÉÌ | |
36505-84-7 | ¶¡ÂÝ»·Íª; 8-[4-(à×à¤-2-»ù)-1-ßßົù¶¡»ù]-8-µªÔÓÂÝ[4,5]¹ïÍé-7,9-¶þͪ | Buspirone; 8-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-Azaspiro[4,5]decane-7,9-dione; Buspar | C21H31N5O2 | ÏêÇé | ¹©Ó¦ÉÌ | |
64744-50-9 | 3,3'-ÑÇÎìÏ©»ù-4-¶¡ÄÚõ£°· | Gabapentin-lactam; 3,3-Pentamethylene-4-butyrolactam; 2-Azaspiro[4.5]decan-3-one | C9H15NO | ÏêÇé | ¹©Ó¦ÉÌ | |
71526-07-3 | AD-67; 4-¶þÂÈÒÒõ£»ù-1-Ñõ-4-µªÂÝ[4,5]¹ïÍé | AD-67 Antidote; MON-4660; 4-(Dichloroacetyl)-1-oxa-4-Azaspiro[4.5]decane | C10H15Cl2NO2 | ÏêÇé | ¹©Ó¦ÉÌ | |
75776-79-3 | 1,4-¶þÁò-7-µªÔÓÂÝ[4,4]ÈÉÍé-8-ôÈËáÇâäåËáÑÎ | 1,4-Dithia-7-Azaspiro[4,4]nonane-8-carboxylic acid hydrobromide; 1,4-DITHIA-7-AzaspirO[4,4]NONANE-8-CARBOXYLIC ACID HBR; 1,4-DITHIA-7-AzaspirO[4,4]NONANE-8-CARBOXYLIC ACID HYDROBROMIDE; 1,4-DITHIA-7-AzaspirO(4,4)NONANE-8-(S)-CARBOXYLIC ACID HYDROBROMIDE; (S)-1,4-Dithia-7-Azaspiro[4.4]nonane-8-carboxylic acid hydrobromide; 1,4-Dithia-7-Azaspiro(4,4)Nonane-8-(S)-CarboxylicAcid=ProtiBr; (S)-1,4-Dithia-7-Azaspiro[4.4]nonane-8-Carboxylic Acid HBr; 8-(1,4-DITHIA-7-AzaspirO(4,4)NONANE-8-(S)CARBOXYLICACID)HYDROBROMIDE; 1,4-DITHIA-7-AzaspirO[4,4]NONANE-8-CARBOXYLIC ACID HYDROBROMIDE,(S)- | C7H12BrNO2S2 | ÏêÇé | ¹©Ó¦ÉÌ | |
103255-66-9 | ÅÁÇØ¿Ë¡; 2-(7-ÂÈ-1,8-¶þµªÝÁ-2-»ù)-3-[2-(1,4-¶þÑõ-8-µªÔÓÂÝ[4.5]¸ý-8-»ù)-2-Ñõ´úÒÒ»ù]-3H-ÒìßÅßá-1-ͪ | Pazinaclone; 2-(7-Chloro-1,8-naphthyridin-2-yl)-3-[2-(1,4-dioxa-8-Azaspiro[4.5]decan-8-yl)-2-oxoethyl]-3H-isoindol-1-one | C25H23ClN4O4 | ÏêÇé | ¹©Ó¦ÉÌ | |
127254-12-0 | Î÷ËûɳÐÇ; 7-[(4S)-4-°±»ù-6-µªÔÓÂÝ[2.4]¸ýÍé-6-»ù]-8-ÂÈ-6-·ú-1-[(2S)-2-·ú»·±û»ù]-1,4-¶þÇâ-4-Ñõ´ú-3-àßø | SITAFLOXACIN; 3-Quinolinecarboxylicacid,7-(7-amino-5-Azaspiro[2.4]hept-5-yl)-8-chloro-6-fluoro-1-(2-fluorocyclopropyl)-1,4-dihydro-4-oxo-,[1R-[1a(S*),2a]]-; 5-Azaspiro[2.4]heptane, 3-quinolinecarboxylicacid deriv.; DU 6859; DU 6859a; Gracevit; Sitafloxacin | C19H18ClF2N3O3 | ÏêÇé | ¹©Ó¦ÉÌ | |
138401-24-8 | 4'-[(2-¶¡»ù-4-Ñõ-1,3-¶þµªÔÓÂÝ»·[4.4]ÈÉ-1-Ï©-3-»ù)¼×»ù]Áª±½-2-¼×ëæ; ¶ò±´É³Ì¹Ìþ»¯Îï | 4'-[(2-Butyl-4-oxo-1,3-diAzaspiro[4.4]non-1-en-3-yl)methyl]biphenyl-2-carbonitrile; 4'-[(2-Butyl-4-oxo-1,3-diAzaspiro[4.4]non-1-en-3-yl)methyl]-(1,1'-biphenyl)-2-carbonitrile | C25H27N3O | ÏêÇé | ¹©Ó¦ÉÌ | |
138402-10-5 | Èý±½¼×»ù¶ò±´É³Ì¹; Èý±½¼×»ùÒÀ±´É³Ì¹ | Trityl Irbesartan; 2-Butyl-3-[[4-[2-(2-trityl-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diAzaspiro[4.4]non-1-en-4-one | C44H42N6O | ÏêÇé | ¹©Ó¦ÉÌ | |
138402-11-6 | ¶ò±´É³Ì¹; 2-¶¡»ù-3-[4-[2-(1H-ËÄßò-5-»ù)±½»ù]Üлù]-1,3-¶þµªÔÓÂÝ-[4.4]ÈÉ-1-Ï©-4-ͪ | Irbesartan; 3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diAzaspiro[4.4]non-3-en-1-one | C25H28N6O | ÏêÇé | ¹©Ó¦ÉÌ | |
151257-01-1 | 2-¶¡»ù-1,3-¶þµªÔÓÂÝ»·[4,4]ÈÉ-1-Ï©-4-ͪÑÎËáÑÎ; ¶ò±´²àÁ´ÑÎËáÑÎ | 2-Butyl-4-spirocyclopentane-2-imidazolin-5-one hydrochloride; 1,3-DiAzaspiro[4.4]non-1-en-4-one,2-butyl-, monohydrochloride (9CI); 2-Butyl-1,3-diAzaspiro[4.4]non-1-en-4-onehydrochloride | C11H19ClN2O | ÏêÇé | ¹©Ó¦ÉÌ | |
167887-97-0 | Å·ÀɳÐÇ; (S)-(-)-5-°±»ù-7-(7-°±»ù-5-µªÔÓÂÝ[2,4]¸ýÍé-5-»ù)-1-»·±û»ù-6-·ú-1,4-¶þÇâ-8-¼×»ù-4-Ñõ´úàßø-3 | Olamufloxacin; (S)-(-)-5-Amino-7-(7-amino-5-Azaspiro[2,4]hept-5-yl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methyl-4-oxoquinoline-3-carboxylic acid | C20H23FN4O3 | ÏêÇé | ¹©Ó¦ÉÌ | |
236406-55-6 | 2-Ê嶡ÑõôÊ»ù-2,7-¶þµªÔÓÂÝ[3.5]ÈÉÍé | 2-(tert-Butoxycarbonyl)-2,7-diAzaspiro[3.5]nonane; 1,1-Dimethylethyl2,7-diAzaspiro[3.5]nonane-2-carboxylate; 2-(tert-Butoxycarbonyl)-2,7-diAzaspiro[3.5]nonane | C12H22N2O2 | ÏêÇé | ¹©Ó¦ÉÌ | |
791828-58-5 | °¢µÃ°Í˾; (6S,7S)-7-[(ôÇ»ù°±»ù)¼×õ£»ù]-6-[(4-±½»ù-1-ßßົù)¼×õ£»ù]-5-µªÔÓÂÝ[2.5]ÐÁÍé-5-¼×Ëá¼×õ¥ | Aderbasib; (6S,7S)-7-[(Hydroxyamino)carbonyl]-6-[(4-phenyl-1-piperazinyl)carbonyl]-5-Azaspiro[2.5]octane-5-carboxylic acid methyl ester | C21H28N4O5 | ÏêÇé | ¹©Ó¦ÉÌ | |
885272-17-3 | 2,6-¶þµªÔÓÂÝ[3.5]ÈÉÍé-6-¼×ËáÊ嶡õ¥ | tert-Butyl 2,6-diAzaspiro[3.5]nonane-6-carboxylate; benzyl 1,3-dioxoisochroman-6-ylcarbamate; tert-Butyl 2,6-diAzaspiro[3.5]nonane-6-carboxylate; 2,6-Diaza-spiro[3.5]nonane-2-carboxylic acid tert-butyl ester | C12H22N2O2 | ÏêÇé | ¹©Ó¦ÉÌ | |
896464-16-7 | 2,7-¶þµªÔÓÂÝ[3.5]ÈÉÍé-7-¼×ËáÊ嶡õ¥ | tert-Butyl 2,7-diAzaspiro[3.5]nonane-7-carboxylate; 2,7-DiAzaspiro[3.5]nonane-7-carboxylic acid 1,1-dimethylethyl ester | C12H22N2O2 | ÏêÇé | ¹©Ó¦ÉÌ | |
82537-67-5 | 8-ÒÒõ£»ù-3-Ê®¶þÍé»ù-7,7,9,9-Ëļ׻ù-1,3,8-ÈýµªÔÓÂÝ[4.5]¹ïÍé-2,4-¶þͪ | 3,8-TriAzaspiro[4.5]decane-2,4-dione, 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1 8-triAzaspiro[4.5]dec; 8-Acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triAzaspiro[4.5]decane-2,4-dione; C 10-440; Sanol LS 440; Tinuvin 440 | C25H45N3O3 | ÏêÇé | ¹©Ó¦ÉÌ | |
168296-18-2 | Acetic acid,(2E)-(2,8-dimethyl-1-oxa-8-Azaspiro[4.5]dec-3-ylidene)hydrazide (9CI); Aceticacid, (2,8-dimethyl-1-oxa-8-Azaspiro[4.5]dec-3-ylidene)hydrazide, (E)-; ARL15424 | C12H21N3O2 | ÏêÇé | ¹©Ó¦ÉÌ |